10. Kong JT, Grigg ME, Uyetake L, Parmley SF, Boothroyd JC (2003) Serotyping of Toxoplasma gondii infections in humans using synthetic peptides. J Infect Dis 187: 1484–1495. 11. Jung C, Lee CY, Grigg ME (2004) The SRS superfamily of Toxoplasma surface antigens. Int J Parasitol 34: 285–296. 12. Fazaeli A, Carter PE, Darde´ ML, Pennington TH (2000) Molecular typing of Toxoplasma gondii strains by GRA6 gene sequence analysis. Int J Parasitol 30: 637–642. 13. Jacobs D, Vercammen M, Saman E (1999) Evaluation of recombinant dense granule antigen 7 (GRA7) of Toxoplasma gondii for detection of immunoglobulin G antibodies and analysis of a major antigenic domain. Clin Diagn Lab Immunol 6: 24–29. 14. Sibley LD, Boothroyd JC (1992) Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature (Lond) 359: 82–85. 15. Radke JR, Striepen B, Guerini MN, Jerome ME, Roos DS, et al. (2001) Defining the cell cycle for the tachyzoite stage of Toxoplasma gondii. Mol Biochem Parasitol 115: 165–175. 16. Barragan A, Sibley LD (2002) Transepithelial migration of Toxoplasma gondii is linked to parasite motility and virulence. J Exp Med 195: 1625–1633. 17. Mordue DG, Monroy F, La Regina M, Dinarello CA, Sibley LD (2001) Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. J Immunol 167: 4574–4584. 18. Howe DK, Honore´ S, Derouin F, Sibley LD (1997) Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis. J Clin Microbiol 35: 1411–1414. 19. Fuentes I, Rubio JM, Ram´ırez C, Alvar J (2001) Genotypic characterization of Toxoplasma gondii strains associated with human toxoplasmosis in Spain: direct analysis from clinical samples. J Clin Microbiol 39: 1566–1570. 20. Khan A, Su C, German M, Storch GA, Clifford D, et al. (2005) Genotyping of Toxoplasma gondii strains from immunocompromised patients reveals high prevalence of type I strains. J Clin Micro 43: 5881–5887. 21. Darde´ ML, Villena I, Pinon JM, Beguinot I (1998) Severe toxoplasmosis caused by a Toxoplasma gondii strain with a new isotype acquired in French Guyana. J Clin Microbiol 36: 324. 22. Carme B, Bissuel F, Ajzenberg D, Bouyne R, Aznar C, et al. (2002) Severe acquired toxoplasmsis in immunocompetent adult patients in French Guiana. J Clin Microbiol 40: 4037–4044. 23. Khan A, Jordan C, Muccioli C, Vallochi AL, Rizzo LV, et al. (2006) Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis Brazil. Emerg Infect Dis 12: 942–949. 24. Grigg ME, Ganatra J, Boothroyd JC, Margolis TP (2001) Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis 184: 633–639. 25. Saeij JPJ, Coller S, Boyle JP, Jerome ME, White ME, et al. (2007) Toxoplasma co- opts host gene expression by injection of a polymorphic kinase homologue. Nature 445: 324–327. 26. Saeij JPJ, Boyle JP, Coller S, Taylor S, Sibley LD, et al. (2006) Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 314: 1780–1783. 27. Taylor S, Barragan A, Su C, Fux B, Fentress SJ, et al. (2006) A secreted serine- threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science 314: 1776–1780. 28. Boothroyd JC, Dubremetz JF (2008) Kiss and spit: the dual roles of Toxoplasma rhoptries. Nat Rev Microbiol 6: 79–88. 29. Bradley PJ, Sibley LD (2007) Rhoptries: an arsenal of secreted virulence factors. Curr Opin Microbiol 10: 582–587. 30. El Hajj H, Lebrun M, Arold ST, Vial H, Labesse G, et al. (2007) ROP18 is a rhoptry kinase controlling the intracellular proliferation of Toxoplasma gondii. PLoS Pathogens 3: e14. 31. El Hajj H, Demey E, Poncet J, Lebrun M, Wu B, et al. (2006) The ROP2 family of Toxoplasma gondii rhoptry proteins: proteomic and genomic characterization and molecular modeling. Proteomics 6: 5773–5784. Population Strucure and Virulence of T. gondii 32. Boyle JP, Saeij JP, Hrada SY, Ajioka JW, Boothroyd JC (2008) Expression QTL mapping of Toxoplasma genes reveals multiple mechanisms for strain-specific differences in gene expression. Euk Cell 7: 1403–1414. 33. Dubey JP (1999) Recent advances in Neospora and neosporosis. Vet Parsitol 84: 349–367. 34. Dubey JP, Frenkel JK (1998) Toxoplasmosis of rats: a review, with considerations of their value as an animal model and their possible role in epidemiology. Vet Parasitol 77: 1–32. 35. Frenkel JK (1953) Host, strain and treatment variation as factors in the pathogenesis of toxoplasmosis. Am J Trop Med Hyg 2: 390–415. 36. Weiss LM, Kim K (2007) Bradyzoite development. In: Weiss LM, Kim K, eds. Toxoplasma gondii the model apicomplexan: perspectives and methods. New York: Academic Press. pp 341–366. 37. Robson KJH, Naitza S, Barker G, Sinden RE, Crisanti A (1997) Cloning and expression of the thrombospondin related adhesive protein gene of Plasmodium berghei. Mol Biochem Parasitol 84: 1–12. 38. Robben PM, Mordue DG, Truscott SM, Takeda K, Akira S, et al. (2004) Production of IL-12 by macrophages infected with Toxoplasma gondii depends on the parasite genotype. J Immunol 172: 3686–3694. 39. Suzuki Y, Conley FK, Remington JS (1989) Differences in virulence and development of encephalitis during chronic infection vary with the strain of Toxoplasma gondii. J Infect Dis 159: 790–794. 40. Liesenfeld O (2002) Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease? J Infect Dis 185: S96–101. 41. Frank SA (1996) Models of parasite virulence. Q Rev Biol 71: 37–78. 42. Mackinnon MJ, Read AF (2004) Virulence in malaria: an evolutionary viewpoint. Philos Trans R Soc Lond B Biol Sci 359: 965–986. 43. Higgins DG, Thompson JD, Gibson TJ (1996) Using CLUSTAL for multiple sequence alignments. Methods Enzymol 266: 382–402. 44. Korber B (2000) HIV signature and sequence variation analysis. In: Rodrigo AG, Learn GH, eds. Computational Analysis of HIV Molecular Sequences. Dordrecht: Kluwer Academic Publishers. 45. Kumar S, Tamura K, Jakobsen IB, Nei M (2001) MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 12: 1244–1245. 46. Nei M, Gojobori T (1986) Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 3: 418–426. 47. Ota T, Nei M (1994) Variance and covariances of the numbers of synonymous and nonsynonymous substitutions per site. Mol Biol Evol 11: 613–619. 48. Kosakovsky-Pond SL, Frost SDW, Muse SV (2005) HyPhy: hypothesis testing using phylogenies. Bioinform 21: 676–679. 49. Bastin P, Bagherzadeh Z, Matthews KR, Gull K (1996) A novel epitope tag system to study protien targeting and organelle biogenesis in Trypanosoma brucei. Molec Biochem Parasitol 77: 235–239. 50. Messina M, Niesman IR, Mercier C, Sibley LD (1995) Stable DNA transformation of Toxoplasma gondii using phleomycin selection. Gene 165: 213–217. 51. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, et al. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25: 386–401. 52. Bandelt HJ, Fortser P, Rohl A (1999) Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol 16: 37–48. 53. Hughes AL, Verra F (2001) A very large long-term effective population size in the virulent human malaria parasite Plasmodium falciparum. Proc Roy Soc Lond 268: 1855–1860. 54. Rich SM, Licht MC, Hudson RR, Ayala FJ (1998) Malaria’s Eve: evidence for a recent population bottleneck throughout the world populations of Plasmodium falciparum. Proc Natl Acad Sci (USA) 95: 4425–4430. 55. Swofford DL (2002) Phylogenetic Analysis Using Parsimony (* and other methods). Sunderland: Sinauer Associates. 56. Gajria B, Bahl A, Brestelli J, Dommer J, Fischer S, et al. (2007) ToxoDB: an integrated Toxoplasma gondii database resource. Nucl Acids Res 36: D553–556. PLoS Genetics | www.plosgenetics.org 14 March 2009 | Volume 5 | Issue 3 | e1000404